Tenofovir Disoproxil Fumarate for Prevention of HIV Infection in Women: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Trial

OBJECTIVES: The objective of this trial was to investigate the safety and preliminary effectiveness of a daily dose of 300 mg of tenofovir disoproxil fumarate (TDF) versus placebo in preventing HIV infection in women. DESIGN: This was a phase 2, randomized, double-blind, placebo-controlled trial. SE...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterson, Leigh, Taylor, Doug, Roddy, Ronald, Belai, Ghiorghis, Phillips, Pamela, Nanda, Kavita, Grant, Robert, Clarke, Edith Essie Kekawo, Doh, Anderson Sama, Ridzon, Renee, Jaffe, Howard S, Cates, Willard
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1876601/
https://www.ncbi.nlm.nih.gov/pubmed/17525796
http://dx.doi.org/10.1371/journal.pctr.0020027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1876601/
https://www.ncbi.nlm.nih.gov/pubmed/17525796
http://dx.doi.org/10.1371/journal.pctr.0020027

Ejemplares similares